Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 42 entries
Sorted by: Best Match Show Resources per page
Amylolytic activity in germinated Agrostemma githago L. seeds.

Planta

de Klerk GJ, Willekens P, Kok H, Jacobsen JV.
PMID: 24233738
Planta. 1986 May;168(1):77-83. doi: 10.1007/BF00407012.

The perisperm of seeds of Agrostemma githago contains starch reserves which constitute 40% of the dry weight of the mature seed. These starch reserves were mostly broken down between 48 and 96 h after initiation of imbibition. (Germination occurred...

Cite
de Klerk GJ, Willekens P, Kok H, et al. Amylolytic activity in germinated Agrostemma githago L. seeds. Planta. 1986;168(1):77-83doi: 10.1007/BF00407012.
de Klerk, G. J., Willekens, P., Kok, H., & Jacobsen, J. V. (1986). Amylolytic activity in germinated Agrostemma githago L. seeds. Planta, 168(1), 77-83. https://doi.org/10.1007/BF00407012
de Klerk, G J, et al. "Amylolytic activity in germinated Agrostemma githago L. seeds." Planta vol. 168,1 (1986): 77-83. doi: https://doi.org/10.1007/BF00407012
de Klerk GJ, Willekens P, Kok H, Jacobsen JV. Amylolytic activity in germinated Agrostemma githago L. seeds. Planta. 1986 May;168(1):77-83. doi: 10.1007/BF00407012. PMID: 24233738.
Copy Download .nbib Format: NLM
Ozone, Sulfur Dioxide, and Ultraviolet B Have Similar Effects on mRNA Accumulation of Antioxidant Genes in Nicotiana plumbaginifolia L.

Plant physiology

Willekens H, Van Camp W, Van Montagu M, Inze D, Langebartels C, Sandermann H.
PMID: 12232381
Plant Physiol. 1994 Nov;106(3):1007-1014. doi: 10.1104/pp.106.3.1007.

We have studied the expression of antioxidant genes in response to near ambient conditions of O3, SO2, and ultraviolet B (UV-B) in Nicotiana plumbaginifolia L. The genes analyzed encode four different superoxide dismutases (SODs), three catalases (Cat1, Cat2, and...

Cite
Willekens H, Van Camp W, Van Montagu M, et al. Ozone, Sulfur Dioxide, and Ultraviolet B Have Similar Effects on mRNA Accumulation of Antioxidant Genes in Nicotiana plumbaginifolia L. Plant Physiol. 1994;106(3):1007-1014doi: 10.1104/pp.106.3.1007.
Willekens, H., Van Camp, W., Van Montagu, M., Inze, D., Langebartels, C., & Sandermann, H. (1994). Ozone, Sulfur Dioxide, and Ultraviolet B Have Similar Effects on mRNA Accumulation of Antioxidant Genes in Nicotiana plumbaginifolia L. Plant physiology, 106(3), 1007-1014. https://doi.org/10.1104/pp.106.3.1007
Willekens, H., et al. "Ozone, Sulfur Dioxide, and Ultraviolet B Have Similar Effects on mRNA Accumulation of Antioxidant Genes in Nicotiana plumbaginifolia L." Plant physiology vol. 106,3 (1994): 1007-1014. doi: https://doi.org/10.1104/pp.106.3.1007
Willekens H, Van Camp W, Van Montagu M, Inze D, Langebartels C, Sandermann H. Ozone, Sulfur Dioxide, and Ultraviolet B Have Similar Effects on mRNA Accumulation of Antioxidant Genes in Nicotiana plumbaginifolia L. Plant Physiol. 1994 Nov;106(3):1007-1014. doi: 10.1104/pp.106.3.1007. PMID: 12232381; PMCID: PMC159625.
Copy Download .nbib Format: NLM
Analysis of scattering lengths in Co/Cu/Co and Co/Cu/Co/Cu spin-valves using a Ru barrier.

Physical review. B, Condensed matter

de Jonge WJ, Strijkers GJ, Swagten HJ, Willekens MM.
PMID: 9984674
Phys Rev B Condens Matter. 1996 Oct 01;54(13):9365-9371. doi: 10.1103/physrevb.54.9365.

No abstract available.

Cite
de Jonge WJ, Strijkers GJ, Swagten HJ, et al. Analysis of scattering lengths in Co/Cu/Co and Co/Cu/Co/Cu spin-valves using a Ru barrier. Phys Rev B Condens Matter. 1996;54(13):9365-9371doi: 10.1103/physrevb.54.9365.
de Jonge WJ, Strijkers, G. J., Swagten, H. J., & Willekens, M. M. (1996). Analysis of scattering lengths in Co/Cu/Co and Co/Cu/Co/Cu spin-valves using a Ru barrier. Physical review. B, Condensed matter, 54(13), 9365-9371. https://doi.org/10.1103/physrevb.54.9365
de Jonge WJ, et al. "Analysis of scattering lengths in Co/Cu/Co and Co/Cu/Co/Cu spin-valves using a Ru barrier." Physical review. B, Condensed matter vol. 54,13 (1996): 9365-9371. doi: https://doi.org/10.1103/physrevb.54.9365
de Jonge WJ, Strijkers GJ, Swagten HJ, Willekens MM. Analysis of scattering lengths in Co/Cu/Co and Co/Cu/Co/Cu spin-valves using a Ru barrier. Phys Rev B Condens Matter. 1996 Oct 01;54(13):9365-9371. doi: 10.1103/physrevb.54.9365. PMID: 9984674.
Copy Download .nbib Format: NLM
Splenic Rupture: A Rare Complication of Extracorporeal Shock Wave Lithotripsy.

Journal of the Belgian Society of Radiology

Willekens I, Brussaard C, Raeymaeckers S, De Coninck V, De Mey J.
PMID: 30039108
J Belg Soc Radiol. 2015 Dec 30;99(2):58-60. doi: 10.5334/jbr-btr.889.

No abstract available.

Cite
Willekens I, Brussaard C, Raeymaeckers S, et al. Splenic Rupture: A Rare Complication of Extracorporeal Shock Wave Lithotripsy. J Belg Soc Radiol. 2015;99(2):58-60doi: 10.5334/jbr-btr.889.
Willekens, I., Brussaard, C., Raeymaeckers, S., De Coninck, V., & De Mey, J. (2015). Splenic Rupture: A Rare Complication of Extracorporeal Shock Wave Lithotripsy. Journal of the Belgian Society of Radiology, 99(2), 58-60. https://doi.org/10.5334/jbr-btr.889
Willekens, Inneke, et al. "Splenic Rupture: A Rare Complication of Extracorporeal Shock Wave Lithotripsy." Journal of the Belgian Society of Radiology vol. 99,2 (2015): 58-60. doi: https://doi.org/10.5334/jbr-btr.889
Willekens I, Brussaard C, Raeymaeckers S, De Coninck V, De Mey J. Splenic Rupture: A Rare Complication of Extracorporeal Shock Wave Lithotripsy. J Belg Soc Radiol. 2015 Dec 30;99(2):58-60. doi: 10.5334/jbr-btr.889. PMID: 30039108; PMCID: PMC6032430.
Copy Download .nbib Format: NLM
Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines.

Blood advances

Zhang Y, He L, Selimoglu-Buet D, Jego C, Morabito M, Willekens C, Diop MK, Gonin P, Lapierre V, Droin N, Solary E, Louache F.
PMID: 29296739
Blood Adv. 2017 Jun 13;1(14):972-979. doi: 10.1182/bloodadvances.2017004903. eCollection 2017 Jun 13.

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder that typically associates with mutations in epigenetic, splicing, and signaling genes. Genetically modified mouse models only partially recapitulate the disease phenotype, whereas xenotransplantation of CMML cells in immunocompromised...

Cite
Zhang Y, He L, Selimoglu-Buet D, et al. Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines. Blood Adv. 2017;1(14):972-979doi: 10.1182/bloodadvances.2017004903.
Zhang, Y., He, L., Selimoglu-Buet, D., Jego, C., Morabito, M., Willekens, C., Diop, M. K., Gonin, P., Lapierre, V., Droin, N., Solary, E., & Louache, F. (2017). Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines. Blood advances, 1(14), 972-979. https://doi.org/10.1182/bloodadvances.2017004903
Zhang, Yanyan, et al. "Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines." Blood advances vol. 1,14 (2017): 972-979. doi: https://doi.org/10.1182/bloodadvances.2017004903
Zhang Y, He L, Selimoglu-Buet D, Jego C, Morabito M, Willekens C, Diop MK, Gonin P, Lapierre V, Droin N, Solary E, Louache F. Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines. Blood Adv. 2017 Jun 13;1(14):972-979. doi: 10.1182/bloodadvances.2017004903. eCollection 2017 Jun 13. PMID: 29296739; PMCID: PMC5737594.
Copy Download .nbib Format: NLM
Ileocolic invagination as a complication of a cecal adenocarcinoma.

Journal of radiology case reports

Willekens I, Vandenbroucke F, Van Nieuwenhove Y, Hoorens A, de Mey J.
PMID: 22470608
J Radiol Case Rep. 2008;2(5):29-32. doi: 10.3941/jrcr.v2i5.45. Epub 2008 Nov 01.

Ileocolic invagination in the adult may be caused by adenocarcinoma and lead to intestinal obstruction. We report a case of a cecal adenocarcinoma that was complicated by an ileocolic invagination in a 38 year old female, diagnosed on a...

Cite
Willekens I, Vandenbroucke F, Van Nieuwenhove Y, et al. Ileocolic invagination as a complication of a cecal adenocarcinoma. J Radiol Case Rep. 2008;2(5):29-32doi: 10.3941/jrcr.v2i5.45.
Willekens, I., Vandenbroucke, F., Van Nieuwenhove, Y., Hoorens, A., & de Mey, J. (2008). Ileocolic invagination as a complication of a cecal adenocarcinoma. Journal of radiology case reports, 2(5), 29-32. https://doi.org/10.3941/jrcr.v2i5.45
Willekens, Inneke, et al. "Ileocolic invagination as a complication of a cecal adenocarcinoma." Journal of radiology case reports vol. 2,5 (2008): 29-32. doi: https://doi.org/10.3941/jrcr.v2i5.45
Willekens I, Vandenbroucke F, Van Nieuwenhove Y, Hoorens A, de Mey J. Ileocolic invagination as a complication of a cecal adenocarcinoma. J Radiol Case Rep. 2008;2(5):29-32. doi: 10.3941/jrcr.v2i5.45. Epub 2008 Nov 01. PMID: 22470608; PMCID: PMC3303242.
Copy Download .nbib Format: NLM
IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes.

Frontiers in neurology

Montagna M, Amir R, De Volder I, Lammens M, Huyskens J, Willekens B.
PMID: 29867738
Front Neurol. 2018 May 17;9:329. doi: 10.3389/fneur.2018.00329. eCollection 2018.

IgLON5-associated encephalitis is a syndrome with different clinical presentations consisting of sleep dysfunction, bulbar dysfunction, chorea, and progressive supranuclear palsy-like symptoms whereas dysautonomy and cognitive decline usually appear in later stages of the disease. We report a case of...

Cite
Montagna M, Amir R, De Volder I, et al. IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes. Front Neurol. 2018;9:329doi: 10.3389/fneur.2018.00329.
Montagna, M., Amir, R., De Volder, I., Lammens, M., Huyskens, J., & Willekens, B. (2018). IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes. Frontiers in neurology, 9329. https://doi.org/10.3389/fneur.2018.00329
Montagna, Massimiliano, et al. "IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes." Frontiers in neurology vol. 9 (2018): 329. doi: https://doi.org/10.3389/fneur.2018.00329
Montagna M, Amir R, De Volder I, Lammens M, Huyskens J, Willekens B. IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes. Front Neurol. 2018 May 17;9:329. doi: 10.3389/fneur.2018.00329. eCollection 2018. PMID: 29867738; PMCID: PMC5966542.
Copy Download .nbib Format: NLM
Improved enhancement in CT angiography with reduced contrast media iodine concentrations at constant iodine dose.

Scientific reports

Van Cauteren T, Van Gompel G, Nieboer KH, Willekens I, Evans P, Macholl S, Droogmans S, de Mey J, Buls N.
PMID: 30504863
Sci Rep. 2018 Nov 30;8(1):17493. doi: 10.1038/s41598-018-35918-y.

The study objective is to investigate the impact of a wide range of contrast media (CM) iodine concentrations on CT enhancement at constant total iodine dose (TID) and iodine delivery rate (IDR). Seven injection protocols, based on different iodine...

Cite
Van Cauteren T, Van Gompel G, Nieboer KH, et al. Improved enhancement in CT angiography with reduced contrast media iodine concentrations at constant iodine dose. Sci Rep. 2018;8(1):17493doi: 10.1038/s41598-018-35918-y.
Van Cauteren, T., Van Gompel, G., Nieboer, K. H., Willekens, I., Evans, P., Macholl, S., Droogmans, S., de Mey, J., & Buls, N. (2018). Improved enhancement in CT angiography with reduced contrast media iodine concentrations at constant iodine dose. Scientific reports, 8(1), 17493. https://doi.org/10.1038/s41598-018-35918-y
Van Cauteren, Toon, et al. "Improved enhancement in CT angiography with reduced contrast media iodine concentrations at constant iodine dose." Scientific reports vol. 8,1 (2018): 17493. doi: https://doi.org/10.1038/s41598-018-35918-y
Van Cauteren T, Van Gompel G, Nieboer KH, Willekens I, Evans P, Macholl S, Droogmans S, de Mey J, Buls N. Improved enhancement in CT angiography with reduced contrast media iodine concentrations at constant iodine dose. Sci Rep. 2018 Nov 30;8(1):17493. doi: 10.1038/s41598-018-35918-y. PMID: 30504863; PMCID: PMC6269421.
Copy Download .nbib Format: NLM
Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse.

Cancers

Jansen YJL, Willekens I, Seremet T, Awada G, Schwarze JK, De Mey J, Brussaard C, Neyns B.
PMID: 33503861
Cancers (Basel). 2021 Jan 25;13(3). doi: 10.3390/cancers13030442.

No abstract available.

Cite
Jansen YJL, Willekens I, Seremet T, et al. Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse. Cancers (Basel). 2021;13(3)doi: 10.3390/cancers13030442.
Jansen, Y. J. L., Willekens, I., Seremet, T., Awada, G., Schwarze, J. K., De Mey, J., Brussaard, C., & Neyns, B. (2021). Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse. Cancers, 13(3), . https://doi.org/10.3390/cancers13030442
Jansen, Yanina J L, et al. "Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse." Cancers vol. 13,3 (2021). doi: https://doi.org/10.3390/cancers13030442
Jansen YJL, Willekens I, Seremet T, Awada G, Schwarze JK, De Mey J, Brussaard C, Neyns B. Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse. Cancers (Basel). 2021 Jan 25;13(3). doi: 10.3390/cancers13030442. PMID: 33503861; PMCID: PMC7865287.
Copy Download .nbib Format: NLM
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.

Neurology

Gaig C, Compta Y, Heidbreder A, Marti MJ, Titulaer MJ, Crijnen Y, Högl B, Lewerenz J, Erro ME, Garcia-Monco JC, Nigro P, Tambasco N, Patalong-Ogiewa M, Erdler M, Macher S, Berger-Sieczkowski E, Höftberger R, Geis C, Hutterer M, Milán-Tomás A, Martin-Bastida A, Manzanares LL, Quintas S, Höglinger GU, Möhn N, Schoeberl F, Thaler FS, Asioli GM, Provini F, Plazzi G, Berganzo K, Blaabjerg M, Brüggemann N, Farias T, Ng CF, Giordana C, Herrero-San Martín A, Huebra L, Kotschet K, Liendl H, Montojo T, Morata C, Perez JP, Puertas I, Seifert-Held T, Seitz C, Simabukuro MM, Tellez N, Villacieros-Álvarez J, Willekens B, Sabater L, Iranzo A, Cano JS, Dalmau J, Graus F.
PMID: 34380749
Neurology. 2021 Aug 11; doi: 10.1212/WNL.0000000000012639. Epub 2021 Aug 11.

OBJECTIVE: Anti-IgLON5 disease is a recently described neurological disease that shares features of autoimmunity and neurodegeneration. Abnormal movements appear to be frequent and important but have not been characterized and are under-reported. Here we describe the frequency and types...

Cite
Gaig C, Compta Y, Heidbreder A, et al. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. Neurology. 2021;doi: 10.1212/WNL.0000000000012639.
Gaig, C., Compta, Y., Heidbreder, A., Marti, M. J., Titulaer, M. J., Crijnen, Y., Högl, B., Lewerenz, J., Erro, M. E., Garcia-Monco, J. C., Nigro, P., Tambasco, N., Patalong-Ogiewa, M., Erdler, M., Macher, S., Berger-Sieczkowski, E., Höftberger, R., Geis, C., Hutterer, M., Milán-Tomás, A., Martin-Bastida, A., Manzanares, L. L., Quintas, S., Höglinger, G. U., Möhn, N., Schoeberl, F., Thaler, F. S., Asioli, G. M., Provini, F., Plazzi, G., Berganzo, K., Blaabjerg, M., Brüggemann, N., Farias, T., Ng, C. F., Giordana, C., Herrero-San Martín, A., Huebra, L., Kotschet, K., Liendl, H., Montojo, T., Morata, C., Perez, J. P., Puertas, I., Seifert-Held, T., Seitz, C., Simabukuro, M. M., Tellez, N., Villacieros-Álvarez, J., Willekens, B., Sabater, L., Iranzo, A., Cano, J. S., Dalmau, J., & Graus, F. (2021). Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. Neurology, . https://doi.org/10.1212/WNL.0000000000012639
Gaig, Carles, et al. "Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease." Neurology vol. (2021). doi: https://doi.org/10.1212/WNL.0000000000012639
Gaig C, Compta Y, Heidbreder A, Marti MJ, Titulaer MJ, Crijnen Y, Högl B, Lewerenz J, Erro ME, Garcia-Monco JC, Nigro P, Tambasco N, Patalong-Ogiewa M, Erdler M, Macher S, Berger-Sieczkowski E, Höftberger R, Geis C, Hutterer M, Milán-Tomás A, Martin-Bastida A, Manzanares LL, Quintas S, Höglinger GU, Möhn N, Schoeberl F, Thaler FS, Asioli GM, Provini F, Plazzi G, Berganzo K, Blaabjerg M, Brüggemann N, Farias T, Ng CF, Giordana C, Herrero-San Martín A, Huebra L, Kotschet K, Liendl H, Montojo T, Morata C, Perez JP, Puertas I, Seifert-Held T, Seitz C, Simabukuro MM, Tellez N, Villacieros-Álvarez J, Willekens B, Sabater L, Iranzo A, Cano JS, Dalmau J, Graus F. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. Neurology. 2021 Aug 11; doi: 10.1212/WNL.0000000000012639. Epub 2021 Aug 11. PMID: 34380749; PMCID: PMC8520389.
Copy Download .nbib Format: NLM
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives.

Journal of blood medicine

Mondesir J, Willekens C, Touat M, de Botton S.
PMID: 27621679
J Blood Med. 2016 Sep 02;7:171-80. doi: 10.2147/JBM.S70716. eCollection 2016.

Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) are key metabolic enzymes that convert isocitrate to α-ketoglutarate. IDH1/2 mutations define distinct subsets of cancers, including low-grade gliomas and secondary glioblastomas, chondrosarcomas, intrahepatic cholangiocarcinomas, and hematologic malignancies. Somatic point mutations...

Cite
Mondesir J, Willekens C, Touat M, et al. IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives. J Blood Med. 2016;7:171-80doi: 10.2147/JBM.S70716.
Mondesir, J., Willekens, C., Touat, M., & de Botton, S. (2016). IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives. Journal of blood medicine, 7171-80. https://doi.org/10.2147/JBM.S70716
Mondesir, Johanna, et al. "IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives." Journal of blood medicine vol. 7 (2016): 171-80. doi: https://doi.org/10.2147/JBM.S70716
Mondesir J, Willekens C, Touat M, de Botton S. IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives. J Blood Med. 2016 Sep 02;7:171-80. doi: 10.2147/JBM.S70716. eCollection 2016. PMID: 27621679; PMCID: PMC5015873.
Copy Download .nbib Format: NLM
Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review.

Neurology(R) neuroimmunology & neuroinflammation

Musubire AK, Derdelinckx J, Reynders T, Meya DB, Bohjanen PR, Cras P, Willekens B.
PMID: 34663674
Neurol Neuroimmunol Neuroinflamm. 2021 Oct 18;8(6). doi: 10.1212/NXI.0000000000001089. Print 2021 Nov.

BACKGROUND AND OBJECTIVES: Neuromyelitis optica (NMO) is a CNS inflammatory disease that predominantly affects the optic nerves and the spinal cord. It is more frequent in Asian and African populations than in European ones. Data on epidemiology, clinical presentation,...

Cite
Musubire AK, Derdelinckx J, Reynders T, et al. Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review. Neurol Neuroimmunol Neuroinflamm. 2021;8(6)doi: 10.1212/NXI.0000000000001089.
Musubire, A. K., Derdelinckx, J., Reynders, T., Meya, D. B., Bohjanen, P. R., Cras, P., & Willekens, B. (2021). Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review. Neurology(R) neuroimmunology & neuroinflammation, 8(6), . https://doi.org/10.1212/NXI.0000000000001089
Musubire, Abdu Kisekka, et al. "Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review." Neurology(R) neuroimmunology & neuroinflammation vol. 8,6 (2021). doi: https://doi.org/10.1212/NXI.0000000000001089
Musubire AK, Derdelinckx J, Reynders T, Meya DB, Bohjanen PR, Cras P, Willekens B. Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 18;8(6). doi: 10.1212/NXI.0000000000001089. Print 2021 Nov. PMID: 34663674.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 42 entries